Reframe Daily: Prostate cancer pill boosts survival; new breast cancer use for Trodelvy; tremor wristband works; bionic retina brings back sight

Reframe Daily—curated by Christin Chong (neuroscience PhD, Buddhist chaplain, healthtech strategy consultant)—delivers optimistic and credible healthtech updates you won’t find in most popular news outlets, from sources scientists and healthcare providers read and trust.

Today in one sentence: Enzalutamide helped men with returning prostate cancer live longer; Trodelvy used as the first treatment for hard-to-treat breast cancer kept it from getting worse longer than chemo; a wrist-worn nerve-stimulation device eased essential tremor in daily life; and a thin “bionic retina” implant let people with inherited blindness see shapes and letters again.

Pop in the Discord to chat about health →
https://forms.gle/tN3oabFTsDF21VnS8

Weekly personal shares from Christin here →
http://christin.substack.com/

Good news: A common prostate-cancer medicine added to standard hormone shots helped men live longer.

Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer

Market readiness: 🙂🙂🙂🙂🙂 (on-market U.S. drug with strong phase 3 survival benefit in a new setting; label expansion likely but doctors can already use it) 

Good news: A targeted cancer drug (Trodelvy) used alone as first treatment helped people with a tough-to-treat breast cancer keep disease from getting worse longer than chemo.

Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer

Market readiness: 🙂🙂🙂🙂 (drug is already U.S.-approved in later lines; this trial supports a likely first-line label expansion) 

Good news: A wrist-worn nerve-stimulation device eased hand tremor and daily-living problems in a blinded randomized trial.

Transcutaneous Peripheral Nerve Stimulation for Essential Tremor: A Randomized Clinical Trial

Market readiness: 🙂🙂🙂🙂 (class of devices already FDA-cleared for ET; this specific AI-guided device showed clinically meaningful benefit and could be next) 

Good news: An implanted “bionic retina” converted light to electrical signals and restored useful vision in people who were blind from retinal disease.

Subretinal Photovoltaic Implant to Restore Vision in Retinitis Pigmentosa

Market readiness: 🙂🙂🙂 (human trial with promising function gains; still needs larger studies and FDA review, but the path for implantable vision tech is clear)

Thank you for taking the time to take care of yourself and your loved ones.